✦ LIBER ✦

Pioglitazone reduces risk of recurrent stroke in patients with type 2 diabetes

Book ID: 120850120
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2006
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200615540-00062

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pioglitazone reduces urinary podocyte ex

Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria

✍ Tsukasa Nakamura; Chifuyu Ushiyama; Shiwori Osada; Masanori Hara; Noriaki Shimad 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 205 KB

Pioglitazone and oral cancer risk in pat

Pioglitazone and oral cancer risk in patients with type 2 diabetes

✍ Tseng, Chin-Hsiao 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Pioglitazone and thyroid cancer risk in

Pioglitazone and thyroid cancer risk in patients with type 2 diabetes

✍ Tseng, Chin-Hsiao 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 84 KB

Safety and Tolerability of Pioglitazone

Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes

✍ Professor John Dormandy, Mondira Bhattacharya, Anne-Ruth van Troostenburg de Bru 📂 Article 📅 2009 🏛 Springer International Publishing AG 🌐 English ⚖ 289 KB

Reducing the risk of recurrent stroke in

Reducing the risk of recurrent stroke in patients with AF

✍ Robert G Hart; John W Eikelboom 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 102 KB

Withdrawal of pioglitazone in patients w

Withdrawal of pioglitazone in patients with type 2 diabetes mellitus

✍ M. Iwase; T. Asano; N. Sasaki; H. Yoshizumi; S. Hiramatsu; Y. Sakai; A. Ogo; M. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB